Related Experiment Videos
Budd-Chiari syndrome presenting as fulminant hepatic failure
Gut
|September 1, 1986
Summary
Budd-Chiari syndrome, a rare liver condition, can rapidly lead to fulminant hepatic failure. Early diagnosis with non-invasive imaging is crucial for timely treatment and potential liver transplantation.
Area of Science:
- Hepatology
- Vascular Surgery
Background:
- Budd-Chiari syndrome (BCS) is a rare hepatic vascular disease characterized by obstruction of hepatic venous outflow.
- Fulminant hepatic failure (FHF) is a severe complication of liver disease with high mortality.
- Timely diagnosis and intervention are critical for managing BCS presenting with FHF.
Observation:
- Two cases of BCS presenting with encephalopathy within eight weeks of symptom onset, meeting the criteria for FHF, are described.
- One patient, initially suspected of non-A, non-B hepatitis, developed grade 4 coma and died 12 days post-presentation.
- The second patient, misdiagnosed with intra-abdominal malignancy, experienced exacerbated encephalopathy after exploratory laparotomy, leading to death three weeks later.
Findings:
- Necropsy confirmed Budd-Chiari syndrome as the underlying diagnosis in both cases.
- Neither patient underwent non-invasive investigations like ultrasound or isotope scanning, delaying diagnosis.
- Delayed diagnosis precluded consideration for orthotopic liver transplantation, a potentially life-saving treatment for severe BCS-FHF.
Implications:
- This case series highlights the critical importance of considering BCS in patients presenting with FHF.
- Non-invasive diagnostic modalities should be employed early in the diagnostic workup of suspected FHF.
- Prompt diagnosis and consideration for liver transplantation can significantly improve outcomes in severe Budd-Chiari syndrome.